2-valent/bvalent/bHPV vaccine	Bivalent (HPV-16/18)
4-valent/qvalent/qHPV vaccine	Quadrivalent (HPV-6/11/16/18)
9-valent/9vHPV vaccine	Nonavalent (HPV-6/11/16/18/31/33/45/52/58)
AI	Artificial Intelligence
ASHA	Accredited Social Health Activist
Arg	Arginine
CIN	Cervical intraepithelial neoplasia
CIN1	Cervical intraepithelial neoplasia grade 1
CIN2	Cervical intraepithelial neoplasia grade 2
CIN3	Cervical intraepithelial neoplasia grade 3
DNA	Deoxyribonucleic acid
E2F	Early Region 2 binding factor
E6AP	ubiquitin-protein ligase E3A
EGFR	Epidermal growth factor receptor
FDA	Food and Drug Administration
HIV	Human immunodeficiency virus
HLA	Human leukocyte antigen
HPV	Human papillomavirus
HPVs	Human papillomaviruses
hrHPV	High-risk HPV
hTERT	Human telomerase
LBC	Liquid-based cytology
LCR	Long control region
LMICs	Low- and middle-income countries
lrHPV	Low-risk HPV
MHC-I	Major Histocompatibility Complex Class I
mRNA	Messenger RNA
OC	Oral contraceptive
OR	Odds ratio
pRb	Retinoblastoma protein
RE-AIM	Reach, Effectiveness, Adoption, Implementation, and Maintenance
RNA	Ribonucleic acid
SCC	Squamous cell carcinoma
SEER	Surveillance, Epidemiology, and End Results Program
STIs	Sexually transmitted infections
UK	United Kingdom
US	United States
USPSTF	United States Preventive Services Task Force
VIA	Visual inspection with acetic acid
WLWH	Women living with HIV
WHO	World Health Organization